Snowbird Resort Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

NOTES:
This meeting occurs in 2017.
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


Download Flyer

Twitter hashtag for this meeting: #KSbiologics

Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies (A7)

Scientific Organizers: Cherié L. Butts, Amy S. Rosenberg, Amy D. Klion and Sachdev S. Sidhu


January 22—26, 2017

Snowbird Resort, Snowbird, Utah, USA


Sponsored by Genmab A/S, ImmunoGen, Inc., Mersana Therapeutics, Pfizer Inc. and Roche


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks; poster display opportunities remain open.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
Scholarship Deadline: Sep 21, 2016 [details]
Discounted Abstract Deadline: Sep 21, 2016 [details]
Abstract Deadline: Oct 20, 2016 [details]
Discounted Registration Deadline: Nov 21, 2016 [details]


Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2017-A7 "Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On September 21, 2016 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After September 21, 2016 until December 23, 2016 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
September 21, 2016 n/a
Discounted NON-STUDENT Registration
More details
Before and On November 21, 2016 795.00 USD
(includes 150.00 discount)
Regular NON-STUDENT Registration
More details
After November 21, 2016 945.00 USD
Discounted STUDENT Registration
More details
Before and On November 21, 2016 570.00 USD
(includes 150.00 discount)
Regular STUDENT Registration
More details
After November 21, 2016 720.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: September 21, 2016


Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is October 20, 2016)

Global Health Travel Award Deadline:


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: September 21, 2016


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: October 20, 2016


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is September 21, 2016)

Discounted Registration Deadline: November 21, 2016


Registration Fee: 795.00 USD* (includes 150.00 USD discount)
Student Registration Fee: 570.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 945.00 USD*
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, January 22 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, January 26 with a closing plenary session and keynote address from 17:00 to 19:30, followed by a social hour and entertainment. We recommend return travel on Friday, January 27 in order to fully experience the meeting.

SUNDAY, JANUARY 22

16:00—20:00
Arrival and Registration

Ballroom Lobby
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Ballroom Lobby

MONDAY, JANUARY 23

07:00—08:00
Breakfast

Golden Cliff/Eagles
08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 2-3
Arne Skerra, Technical University of Munich, Germany
Advanced Protein Design Concepts for Biopharmaceutical Drug Discovery and Development: Anticalins and PASylation

09:00—11:30
Modified and Alternative Scaffolds as Novel Biotherapeutics
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 2-3
Sachdev S. Sidhu, University of Toronto, Canada
Modulation of Cell Signalling with Synthetic Proteins

Coffee Break

Karl Dane Wittrup, Massachusetts Institute of Technology, USA
Engineering Synergistic Innate and Adaptive Cancer Immunotherapy

Shohei Koide, New York University Langone Medical Center, USA
Controlling Cell Signaling with Designer Binding Proteins

Ken G. Andersson, Royal Institute of Technology, Sweden
Short Talk: Development and Optimization of an E. coli-Based Display Platform for Selection of Affinity Proteins

Takamitsu Hattori, New York University School of Medicine, USA
Short Talk: Antigen Clasping Enables Exceptional Specificity toward Peptides Harboring Post-Translational Modifications

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

Superior/Superior Lobby/Wasatch
13:00—22:00
Poster Viewing

Superior/Superior Lobby/Wasatch
16:30—17:00
Coffee Available

Ballroom Lobby
17:00—19:00
Non-Antibody Scaffolds, Microenvironment Modulators
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 2-3
James W. Lillard, Jr., Morehouse School of Medicine, USA
Novel Protein Antagonists Targeting Chemokine Receptors Involved in Cancer and Inflammatory Diseases

John C. Bell, Ottawa Hospital Research Institute, Canada
Virotherapies

Margaret Karow, Akriveia Therapeutics, USA
Optimizing Biologics for Therapeutic Use

Tim Jones†, Abzena plc, UK
Short Talk: A Deimmunised form of the Ribotoxin, Alpha-Sarcin, Lacking CD4+ T Cell Epitopes and its use as an Immunotoxin warhead

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Superior/Superior Lobby/Wasatch
19:30—22:00
Poster Session 1

Superior/Superior Lobby/Wasatch

TUESDAY, JANUARY 24

07:00—08:00
Breakfast
To encourage networking, particularly among early-career scientists, invited speakers will be available at reserved tables to discuss specific topics.

Table 1 - Novel Drug Design: An Engineer’s Perspective
Table 2 - Careers in Industry: At and Away from the Bench

Golden Cliff/Eagles
08:00—11:30
Enhancing Activity and Tissue-Specific Targeting/Strategies for PK Optimization
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 2-3
Anne S. De Groot, EpiVax, Inc., USA
Novel Methods for Addressing Immunogenicity in Therapeutic Proteins

Nancy M. Dahms, Medical College of Wisconsin, USA
Targeting Muscle Cells

Ashley M. Buckle, Monash University, Australia
Short Talk: Circumventing the Stability-Function Trade-Off in Protein Engineering

Coffee Break

Lynn E. Macdonald, Regeneron Pharmaceuticals, USA
Engineered Mice to Study Novel Antibody and Antibody-Like Molecules

Ruben Boado, ArmaGen, USA
Treatment of Human Lysosomal Storage Disorders with Blood-Brain Barrier Penetrating IgG-fusion Proteins

Andrew D. Baik, Regeneron Pharmaceuticals, USA
Short Talk: Engineering Tissue Specific Delivery of Enzymes for Lysosomal Storage Disease Treatment

11:30—17:00
On Own for Lunch

11:30—13:00
Poster Setup

Superior/Superior Lobby/Wasatch
13:00—22:00
Poster Viewing

Superior/Superior Lobby/Wasatch
16:30—17:00
Coffee Available

Ballroom Lobby
17:00—19:00
Bispecific and Antibody-Drug Conjugates
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 2-3
Jennifer R. Cochran, Stanford University, USA
Designer Multispecific Proteins Based on Natural Ligands

Ariel Munitz, Tel Aviv University, Israel
Targeting ITIM-Bearing Receptors in Mucosal Inflammation

Kisu Kim, Mogam Institute for Biomedical Research, South Korea
Short Talk: Whole IgG Like Bispecific Antibodies Engaging T Cells for Cancer Immunotherapy

Stefan R. Schmidt, Rentschler Biotechnology, Germany
Short Talk: Manufacturing of Complex Biobetters: Half-Life Extended Fusion Proteins and Bispecific Molecules

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Superior/Superior Lobby/Wasatch
19:30—22:00
Poster Session 2

Superior/Superior Lobby/Wasatch

WEDNESDAY, JANUARY 25

07:00—08:00
Breakfast
To encourage networking, particularly among early-career scientists, invited speakers will be available at reserved tables to discuss specific topics.

Table 1 - Clinical Trial Design: Getting it Right
Table 2 - Paradigm Shift: Scientist and Entrepreneur

Golden Cliff/Eagles
08:00—11:15
Different Approaches to Targeting Tumors: Melanoma as an Example
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 2-3
Amy S. Rosenberg, U.S. Food and Drug Administration, USA
Mechanisms for Accelerated Approval, Breakthrough Therapies

Luca Gattinoni, NCI, National Institutes of Health, USA
Harnessing T Memory Stem Cells for Adoptive Cell Transfer Therapy of Cancer

Coffee Break

Pierre Bruhns, Institut Pasteur, France
Microdroplet-Based Massive Kinetic Analyses Reveal Secretion Rate and Affinity from Individual Antibody Secreting Cells

Réjean Lapointe, University of Montreal, CHUM, Canada
Increasing Complexity in Combining Cancer Immunotherapies

Ykelien L. Boersma, University of Groningen, Netherlands
Short Talk: DARPins as Potential Anti-Cancer Therapeutics

James Anthony Torchia†, Massachusetts General Hospital, USA
Short Talk: Targeting Lymphoma with Precision using Semisynthetic Anti-Idiotype Peptibodies

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Superior/Superior Lobby/Wasatch
13:00—22:00
Poster Viewing

Superior/Superior Lobby/Wasatch
16:30—17:00
Coffee Available

Ballroom Lobby
17:00—19:15
Biologics in Autoimmunity/Autoinflammatory Disorders
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 2-3
Virginia Pascual, Baylor Research Institute, USA
SLE

Raphaela Goldbach-Mansky, NIAID, LCID, National Institutes of Health, USA
IL-1-Mediated Autoinflammatory Disorders

Andreas G. Plückthun, University of Zürich, Switzerland
Next Generation Biologics: Exploiting the Opportunities for Protein Engineering

David P. Humphreys, UCB Pharma, UK, UK
Short Talk: Statistical Design for Effector Function Engineering of Hexameric Fc Domains as a Recombinant IVIG Alternative

Takashi K. Kishimoto†, Selecta Biosciences, USA
Short Talk: Developing Biobetters with Improved Efficacy and Safety by Addressing Product Immunogenicity with Tolerogenic Nanoparticles

19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Superior/Superior Lobby/Wasatch
19:30—22:00
Poster Session 3

Superior/Superior Lobby/Wasatch

THURSDAY, JANUARY 26

07:00—08:00
Breakfast
To encourage networking, particularly among early-career scientists, invited speakers will be available at reserved tables to discuss specific topics.

Table 1 - Careers in Government: At and Away from the Bench
Table 2 - Academia vs. Government vs. Industry

Golden Cliff/Eagles
08:00—11:00
Multimodal Approaches to Allergic Inflammation
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 2-3
Amy D. Klion, NIAID, National Institutes of Health, USA
Eosinophil-Targeted Therapy: Lessons Learned from the Treatment of Hypereosinophilic Syndromes

Bruce S. Bochner, Northwestern University Feinberg School of Medicine, USA
Targeting Siglecs in Allergic Inflammatory Disease

Coffee Break

Hector G. Ortega, GlaxoSmithKline, USA
Blocking Eosinophilic Inflammation with Biologics: Current Experience

Mark P. Waterhouse, University of Leeds, UK
Short Talk: Novel Specific Agents for Blocking IgG-Fc?RIIIa Interactions

Katharine D. Grugan, Janssen R&D, USA
Short Talk: The Role of Multiple Fc Gamma Receptors in an Antibody Dependent Cellular Phagocytosis Potency Assay

11:00—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Ballroom Lobby
17:00—18:30
Concept to Clinic to Market
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 3
Cherié L. Butts, Biogen, USA
Strategies for Transforming Ideas into Viable Drug Candidates

Stylianos Bournazos, Rockefeller University, USA
Optimization of Anti-HIV Antibodies for Prevention and Therapy

Teresa S. Wiley, Wiley Systems, Inc, USA
Short Talk: Steroid Hormone Exposure on Regulation of P53 and Bcl-2: Bio-Mimetic Hormone Replacement Therapy and the Quality of Life for Breast Cancer Patients

18:30—19:15
Closing Keynote Address
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 3
Douglas E. Williams, Codiak Biosciences, USA
Exosomes and Extracellular Vesicles: One Man’s Trash is Another Man’s Treasure

19:15—19:30
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 12/22/2016

Ballroom 3
19:30—20:30
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Ballroom 1-2
20:30—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Ballroom 1-2

FRIDAY, JANUARY 27

 
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Genmab A/S ImmunoGen, Inc.
Mersana Therapeutics Pfizer Inc.
Roche
 

We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1R13AI126942-01

Funding for this conference was made possible [in part] by 1R13AI126942-01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Amgen Inc.


Biogen


Codiak Biosciences


EpiVax, Inc.


Regeneron Pharmaceuticals, Inc.


Thermo Fisher Scientific Inc.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Assistant Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676